documents: FDA-2020-D-1136-0084

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-D-1136-0084 FDA FDA-2020-D-1136 Development of Monoclonal Antibody Products Targeting SARS–CoV–2 for Emergency Use Authorization; Guidance for Industry; Availability Notice Notice of Availability 2023-12-21T05:00:00Z 2023 12     2023-12-21T16:06:18Z 2023-28092 0 0 090000648634e184

Links from other tables